Mark T J van Bussel
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 27, 2023
Reported hepatotoxicity and hepatotoxicity guidance in the product information of protein kinase inhibitors in oncology registered at the European Medicines Agency.Marc Maliepaard, Yoran S Faber, Mark T J van Bussel
|Nov 24, 2020
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours.Mark T J van Bussel, Ahmad Awada, Maja J A de Jonge
|Jan 08, 2020
Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases.Mark T J van Bussel, Dick Pluim, Bojana Milojkovic Kerklaan
|Jun 01, 2019
Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review.Mark T J van Bussel, Jos H Beijnen, Dieta Brandsma
Pageof 1
